Menu

Website Search

Pumabiotechnology.com

pumabiotechnology.com
Visit pumabiotechnology.com

  • 829.4K

    Global Rank

  • 474

    Daily Visitors

  • 6 days ago

    Last scanned

  • 13 years

    Domain Age

Pumabiotechnology.com

Visit pumabiotechnology.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered in...

Pumabiotechnology.com thumbnail
Pumabiotechnology.com thumbnail
99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with GoDaddy.com, LLC, which reserves the following IP addresses for pumabiotechnology.com: 50.62.187.33. Moreover, DNS used with this website include ns67.domaincontrol.com, ns68.domaincontrol.com. Subnet identifier ranges from 50.62.0.0 to 50.63.255.255. Classless Inter-Domain Routing (CIDR) is 50.62.0.0/15. ARIN net type is Direct Allocation.

  • 829.4K

    Global Rank

  • 474

    Daily Visitors

  • 6 days ago

    Last scanned

  • 13 years

    Domain Age

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of pumabiotechnology.com is GODADDY.COM, LLC and the name expires on 2024-08-26. Owner email is obscured for security reasons, so you cannot reach them directly. Their country of residence is United States of America.

  • biotechnology
  • cancer treatment
  • ovarian cancer
  • early stage
  • control
  • head and neck cancer
  • drug development
  • metastatic
  • small cell lung cancer
  • biliary cancer

Websites similar to pumabiotechnology.com